Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Joseph D’Orazio Provides Perspective to the New York Times about Xylazine

View All News

Joseph D’Orazio, MD, Associate Professor of Clinical Emergency Medicine at the Lewis Katz School of Medicine at Temple University, provided perspective to the New York Times about xylazine (also known as Tranq, Tranq dope and zombie drug). Xylazine is an animal sedative that has been increasingly found in fentanyl and heroin and causes fast-moving necrotic wounds and heavy sedation. Dr. D’Orazio discussed the signs and symptoms of a xylazine overdose, its effects on the skin, withdrawal symptoms, and xylazine management.